Mesh Bio, founded in 2018, is a fast-growing digital health startup based in Singapore. The company specializes in developing AI-powered clinical decision support, analytics, and automation solutions tailored for healthcare providers. With its mission encapsulated in its slogan, "Multidimensional Health Intelligence Platform for digital twin and computational biology enabled care delivery", Mesh Bio is aiming to transform healthcare delivery with digital solutions.
Operating at the intersection of AI, Analytics, Biotechnology, Health Care, and Information Technology, the company has cultivated an environment that emphasizes personal excellence, career growth, and diversity.
Mesh Bio recently secured a $3.50M Series A investment on 12 October 2023, attracting investors like East Ventures, Elev8.VC, Seed Capital, and Selvedge Venture. This funding round accentuates the company’s potential to further expand its innovative offerings in the healthcare sector.